Published: Mar 6, 2026
Written by Klarity Editorial Team
Published: Mar 6, 2026

If you’re a psychiatrist or psychiatric nurse practitioner watching the GLP-1 explosion, you’ve probably wondered: Should I be offering weight-loss services in my practice?
It’s a fair question. You didn’t go into psychiatry to become a weight-loss doctor. But here’s the reality: your patients are already asking about it. They’re struggling with 30+ pounds of antipsychotic-induced weight gain. They’re scrolling Instagram seeing Ozempic transformations. And increasingly, they’re booking appointments with telehealth startups that promise easy access to semaglutide—often without the behavioral health expertise you bring to the table.
The numbers tell the story: 8-10% of Americans are currently using GLP-1 medications, with another 30-35% expressing interest. That’s roughly 50 million potential patients actively seeking providers who can prescribe and manage these medications. The weight-loss telehealth market hit $6.9 billion in 2023 and continues growing at 8%+ annually.
For psychiatric providers specifically, there’s a unique opportunity here. You already understand the intersection of mental health and metabolic issues. You’re managing medications that cause weight gain. And emerging evidence shows GLP-1s not only help patients lose weight—they may actually improve mood and quality of life in people with obesity and mental health conditions.
Let’s break down whether adding weight-loss services makes sense for your practice, what the actual economics look like, and how to grow this revenue stream without turning into something you’re not.
Here’s what most weight-loss clinics miss: obesity and mental health are deeply intertwined. Research shows that patients with psychological distress or eating disorders are more likely to seek out GLP-1 medications. Many of your existing patients are probably in this group.
Consider the typical scenarios:
Traditional weight-loss clinics treat these patients like everyone else: prescribe the med, maybe add a generic diet plan, see you in a month. But you know better. You understand that the woman with atypical depression needs a different approach than someone with binge eating disorder. You can recognize when rapid weight loss is triggering anxiety or when patients are developing disordered eating patterns around GLP-1 side effects.
Dr. Spencer, a psychiatrist specializing in metabolic psychiatry, puts it plainly: ‘These systems are inseparable. Treating metabolic illness can improve mental health, and vice versa.’ The evidence backs this up—multiple studies show GLP-1 medications improve quality of life metrics and mood in patients with obesity, independent of weight loss alone.
If you prescribe antipsychotics, mood stabilizers, or certain antidepressants, you’re already managing weight as a clinical issue. Traditionally, your options were limited: switch medications (if clinically appropriate), add metformin, or refer to bariatrics.
Now there’s another tool in the toolbox. Guidelines from the American Psychiatric Association recognize that when lifestyle modifications and metformin aren’t enough for antipsychotic-induced weight gain, GLP-1 medications become a reasonable option.
This isn’t mission creep—it’s integrated care. You’re not abandoning psychiatry to become a weight-loss specialist. You’re addressing a complication of psychiatric treatment that significantly impacts adherence, quality of life, and medical outcomes.
The weight-loss telehealth space is crowded with players who are essentially prescription mills. Initial video visit, here’s your Wegovy, see you when you need a refill. Many of these services employ physicians or NPs who’ve done a weekend course in obesity medicine and are churning through 30+ patients a day.
You can differentiate by offering something these clinics can’t: genuine expertise in the behavioral and psychiatric aspects of weight management.
That means:
This approach won’t appeal to every patient. Some people just want a script and to be left alone. But for a significant segment—especially those with complex mental health histories—your integrated model is exactly what they need and are willing to pay for.
Let’s talk money, because that’s ultimately what determines whether this is worth your time.
The typical telehealth weight-loss patient spends approximately $600-800 per year on provider services (not including medication costs). This breaks down to:
The medication itself is separate—branded GLP-1s run $900-1,300/month retail, though insurance coverage is expanding rapidly. Many patients use:
Your service revenue comes from the medical management, not the drug itself (unless you’re dispensing, which adds complexity).
Option 1: Cash-Pay Add-On to Existing Practice
You already see psychiatric patients. Offer weight management as an additional service for appropriate candidates (those with medication-related weight gain, BMI >27 with comorbidities, etc.).
Pricing:
Potential Revenue: If you see 20 weight-management patients monthly, that’s $1,500-2,500/month in additional revenue ($18-30K annually), with minimal overhead beyond your existing practice costs.
Option 2: Insurance-Based Model
If you accept insurance, you can bill standard E&M codes for obesity counseling and medication management. Medicare and most commercial plans cover these services:
Reimbursement varies but typically $80-150 per visit depending on code level and payer. The upside: you’re in-network for patients already seeking your services. The downside: administrative burden and lower reimbursement than cash.
Option 3: Hybrid/Platform Model
Partner with a telehealth platform that handles patient acquisition, scheduling, and payment processing. You see patients virtually and get paid per visit (typically $100-150 per appointment).
Platforms like Klarity Health use a pay-per-appointment model: no upfront marketing costs, no subscription fees. You only pay when you actually see a patient—usually a flat fee per completed visit. This removes all patient acquisition risk.
The economics here are straightforward: every patient who books with you is net-positive revenue. Compare this to spending $3,000-5,000/month on Google Ads, SEO consultants, and directory listings with uncertain ROI.
Let’s be brutally honest about what it costs to acquire weight-loss patients on your own:
DIY Marketing Real Costs:
Total monthly marketing spend for DIY approach: $3,000-7,000+ with 3-6 month ramp-up before positive ROI.
Factor in:
Reality: A qualified psychiatric patient booking for weight management through paid ads typically costs $200-500 all-in when you account for everything. And that’s if you have the expertise to run effective campaigns—most solo practitioners don’t.
Platform Model Economics:
Instead of spending thousands monthly gambling on marketing with uncertain results, platforms like Klarity handle patient acquisition and match pre-qualified patients to your profile. You pay a standard fee per completed appointment (similar to Zocdoc’s model).
The value proposition:
The guaranteed ROI difference: Instead of spending $5,000/month hoping to generate enough patient volume, you pay only when someone actually books and completes an appointment with you. Every transaction is profitable from day one.
For most providers, especially those building or scaling a practice, this model eliminates the primary risk of growth: wasting money on marketing that doesn’t convert.
Be realistic about time. Each weight-loss patient requires:
If you’re adding 10 weight-loss patients to your practice, expect 5-8 hours/month in direct patient care, plus 1-2 hours handling messages and prior authorizations.
The key question: Does that time generate enough revenue to justify taking it away from other clinical activities? For most providers, if you’re clearing $100-150 per hour of direct patient time after overhead, it pencils out well.
Your ability to expand weight-loss services depends heavily on where you’re licensed and what provider type you are.
Full Practice Authority States (NPs/PMHNPs):
California: As of January 2026, California NPs with 3+ years of supervised experience (4,600 hours) can practice independently without physician collaboration. This means PMHNPs in CA can legally run their own weight-management telehealth practice after meeting requirements. This is huge—you can scale without needing an MD partner.
New York: NPs with >3,600 hours of experience (roughly 2 years full-time) have full practice authority. Experienced PMHNPs in NY can operate independently, including offering weight-loss services via telehealth statewide.
Illinois: APRNs can apply for full practice authority after 4,000 clinical hours plus 250 hours of continuing education. Once granted, no physician collaboration needed. Illinois PMHNPs meeting these criteria can independently manage weight-loss patients.
Restricted Practice States:
Texas: NPs must have a physician collaboration agreement to prescribe. If you’re a PMHNP in Texas wanting to offer weight management, you’ll need to partner with a psychiatrist or other physician who’s willing to supervise that aspect of your practice. This adds complexity and cost (collaboration agreements typically run $1,000-3,000/year or revenue-sharing arrangements).
Pennsylvania: Currently restricted—NPs need collaborative agreements. Legislation for full practice authority has been proposed multiple times but not yet passed. PA PMHNPs will need physician backup to prescribe GLP-1s.
Florida: Complicated. Florida created autonomous practice for some APRNs (family NPs, adult NPs in primary care) but psychiatric NPs were excluded. PMHNPs in Florida still need physician collaboration. However, experienced family NPs in Florida can practice independently and offer weight management.
For Psychiatrists (MD/DO): No restrictions in any state—you can practice independently and prescribe in your scope across state lines with appropriate licensing.
Multi-State Practice: If you want to see patients in multiple states via telehealth, you need to be licensed in each state (with limited exceptions):
Florida offers out-of-state telehealth provider registration—you can treat Florida patients without a full FL license if you hold a valid license elsewhere and register with Florida. This opens FL’s large market more easily.
Interstate Medical Licensure Compact (IMLC): Physicians in compact states can more easily obtain licenses in other compact states. New York, Pennsylvania, and Illinois are in the compact. California, Texas, and Florida are not. This matters if you want to scale nationally.
NP Compact: Some states participate in the Nurse Licensure Compact, allowing multi-state practice. However, this is separate from prescriptive authority, which still requires individual state APRN licenses in most cases.
Bottom line: To legally treat patients via telehealth, you need to be licensed where the patient is located. Plan your expansion based on where you can most easily obtain licenses and where demand is highest.
This is where state-level differences dramatically impact your patient base:
States with Medicaid Coverage for Obesity GLP-1s:
California: Medi-Cal covers Wegovy, Saxenda, and Zepbound for obesity. California’s Medicaid program spent $1.4 billion on GLP-1s in 2024, indicating massive patient uptake. If you see Medicaid patients in CA, you can tap this market.
Pennsylvania: Pennsylvania Medicaid covers obesity medications—spent $298M in 2024. Strong opportunity to serve Medicaid population with weight management.
States Without Medicaid Coverage:
New York: Medicaid only covers GLP-1s for diabetes, not obesity. You’ll primarily serve commercially insured or cash-pay patients.
Illinois: Similar—no Medicaid coverage for obesity-only indications. Cash or commercial insurance patients.
Florida: Florida Medicaid has very limited coverage even for diabetes GLP-1s, and no coverage for obesity. Most patients will be cash-pay or use manufacturer assistance programs.
Texas: Partial coverage—some Texas Medicaid MCOs cover Wegovy, but many don’t. Variable access.
Why This Matters: If you’re in a state where Medicaid covers obesity meds, you can reach a broader patient population and potentially see better retention (patients can afford to stay on medication long-term). In states without coverage, you’ll focus on higher-income patients or help patients navigate manufacturer savings programs and compounded alternatives.
Controlled Substances: If you plan to prescribe any appetite suppressants that are controlled substances (like phentermine), pay attention to both federal and state rules:
Federal (DEA): The temporary COVID-era waiver allowing telehealth prescribing of controlled substances without an in-person visit expires December 31, 2025. Starting January 2026, new patients will need at least one in-person examination before you can prescribe controlled substances via telehealth (under the Ryan Haight Act).
State Variations: Florida explicitly prohibits teleprescribing Schedule II substances except in narrow circumstances (psychiatric care, chronic illness management). For weight loss, this mainly affects older stimulant-based diet pills—not a major issue for GLP-1 practices.
GLP-1 medications (semaglutide, tirzepatide) are NOT controlled substances, so you can prescribe them via telehealth in any state where you’re licensed, regardless of these controlled substance restrictions. This is a major advantage—you can run a fully virtual GLP-1 practice without in-person visit requirements.
Understanding patient search behavior helps you capture this demand:
Analysis of Google search data shows what people are actually typing:
Notice the pattern: Patients search for the medication first, provider second. They know what they want—they’re looking for someone who can prescribe it.
This means your website and online profiles need to explicitly mention GLP-1s, Wegovy, Ozempic, semaglutide by name. Don’t be coy with generic ‘medical weight management’ language. Say clearly: ‘We prescribe and manage GLP-1 medications including semaglutide and tirzepatide for weight loss.’
Market research identifies several key patient types seeking GLP-1 services:
1. The Silent Sufferer
Your angle: Emphasize compassionate, confidential virtual care. Marketing messages like ‘Private video visits—no waiting room, no judgment’ resonate strongly.
2. The Busy Parent/Professional
Your angle: Highlight flexible scheduling, 100% virtual options, evening/weekend availability. ‘See a board-certified psychiatrist from home—appointments available 7 days a week.’
3. The Informed Researcher
Your angle: Demonstrate expertise—blog posts citing clinical studies, clear explanations of how medications work, transparent about realistic expectations. ‘Led by Dr. [Name], board-certified psychiatrist specializing in metabolic psychiatry.’
4. The Medication Weight Gain Patient
Your angle: This is your ideal patient—someone who needs exactly what you offer. Content targeting this group (‘Managing Weight Gain from Psychiatric Medications: New Options’) will attract qualified patients who value your dual expertise.
Research shows several factors increase conversion from browsers to booked patients:
1. Social Proof
Weight loss is visual—people want to see that it works. Gather and showcase (with permission) patient success stories.
2. Transparency on Cost
Patients hate surprises. List your cash-pay rates prominently. If you accept certain insurances, say so. If you help patients navigate manufacturer savings programs, mention it.
3. Fast Access
The patient motivated to start weight loss today won’t wait 3 weeks for an appointment. They’ll book with whoever can see them first. Optimize your availability or partner with a platform that manages scheduling efficiently.
4. Comprehensive Support
Patients fear being handed a prescription and left to figure things out. Emphasize your ongoing care model: ‘Monthly check-ins, unlimited messaging for questions, personalized titration based on your response.’
Growing a weight-loss patient base requires smart marketing, not just throwing money at Google Ads.
Why it works: Weight-loss patients are actively researching. They’re reading articles, watching videos, comparing options before booking. If your content answers their questions, you become the trusted expert.
Data shows content marketing generates 3× more leads than paid ads at 62% lower cost. That’s because educational content has compounding value—one well-written blog post can rank in Google and bring patients for years at zero ongoing cost.
What to create:
Educational blog posts: ‘What to Expect on Semaglutide: Month-by-Month Results,’ ‘Managing Nausea on GLP-1 Medications,’ ‘Can Psychiatrists Prescribe Weight-Loss Drugs?’
Condition-specific content: ‘Weight Gain from Antipsychotics: Treatment Options,’ ‘Binge Eating Disorder and GLP-1 Medications’
Local SEO content: ‘GLP-1 Weight Loss Doctors in [City]’—include your city/state multiple times, discuss state-specific insurance coverage
FAQ page with schema markup answering common questions patients search
Frequency: Posting 2-4 times monthly is plenty. Quality over quantity—one well-researched 1,500-word article beats five shallow 300-word posts.
SEO basics: Use your target keywords naturally in titles, first paragraph, and subheadings. Link internally between related posts. Build backlinks by contributing guest posts to local health blogs or getting listed in ‘best weight-loss doctors’ roundups.
Timeline: Content marketing takes 6-12 months to gain traction, but once established, it becomes your lowest-cost patient source.
Building an email list gives you a direct channel to potential patients—no algorithm or ad costs involved.
Email marketing returns an average of $42 for every $1 spent—higher ROI than any other digital channel.
How to build a list:
Offer a lead magnet: ‘Free Guide: 10 Questions to Ask Your Doctor About GLP-1 Medications’ in exchange for email signup
Pop-up on your website: ‘Get weight-loss tips from a psychiatrist—join 500+ subscribers’
Capture emails from initial inquiries (with permission)
What to send:
Welcome sequence (3-5 emails): Introduce yourself, share your approach, address common concerns, make booking easy
Weekly or biweekly newsletter: Quick tips, answer one FAQ, share a recent blog post, patient success snippet
Re-engagement campaign: For people who inquired but didn’t book—’Still considering weight-loss treatment? Here’s what current patients are experiencing…’
Don’t: Spam people or sell aggressively. Provide value first. The email list is a long-term asset—nurture it.
Paid ads can work for weight loss, but you need to be strategic:
Google Ads:
Target longer, more specific keywords: ‘psychiatrist for weight loss Chicago’ vs. just ‘weight loss doctor’ (too expensive, too broad)
Use location targeting aggressively—only serve ads in your licensed states
Create separate campaigns for different patient personas (e.g., one for medication-induced weight gain, another for general obesity)
Set a clear budget and cost-per-acquisition target: If patient lifetime value is $600, your CPA should ideally be under $150 for healthy margins
Expect to test multiple ad variations and landing pages before finding winners
Facebook/Instagram Ads:
Visual platforms work well for before/after stories (follow platform guidelines on health claims)
Target by interests: health and wellness, weight loss, mental health, telehealth
Use video content—short testimonials or ‘A Day in Our Weight-Loss Program’ clips perform well
Retarget website visitors who didn’t book (most people need 5-7 touches before deciding)
Budget recommendation: Start with $1,000-1,500/month if testing paid ads. Track everything—cost per click, cost per lead, cost per booked patient. If you’re not seeing at least 3:1 return within 3 months, pause and invest more in organic channels.
Reality check: Most solo practitioners will do better by investing in SEO/content and partnering with platforms for patient acquisition rather than running ads themselves. Advertising is expensive and requires expertise to optimize.
Key directories to claim:
Keep all listings updated and consistent (same name, address, phone, services offered).
Reviews matter enormously: Prospective patients read reviews before booking. Encourage satisfied patients to leave Google reviews or testimonials.
Send a follow-up email 2-3 weeks after successful initial visit asking for feedback
Provide direct links to your Google or other review profiles
Respond professionally to every review (thank positive ones, address concerns in negative ones constructively)
Target: Aim for 20+ Google reviews with 4.5+ star average. This significantly boosts local search rankings and patient trust.
Don’t overlook old-school networking:
Primary care physicians: Many PCPs are uncomfortable managing weight-loss meds themselves. Offer to be their go-to referral for complex obesity cases, especially those with mental health comorbidities. Host a lunch-and-learn at local practices.
Therapists and psychologists: They can’t prescribe but often have patients who need weight management. Build relationships with local therapists—refer patients back and forth.
Bariatric surgeons: Patients who don’t qualify for surgery or prefer non-surgical options can be referred to you. Surgeons often appreciate having a medical weight management option to offer.
Endocrinologists: Many focus on diabetes and don’t want to manage the behavioral aspects of obesity. Position yourself as complementary.
Referral patients convert at much higher rates than cold leads (they arrive with trust already established) and cost nearly nothing to acquire. Invest time in relationship-building.
Let’s put together a realistic growth scenario:
Year One Goals (Part-Time Weight Management)
Revenue:
Time investment:
Patient acquisition costs:
Year Two Goals (Scaling Up)
Revenue:
At this scale, weight-loss services represent a meaningful revenue stream—potentially 20-30% of total practice income for a part-time psychiatry practice, or a full-time focus if you build it out.
Pitfall #1: Scope Creep
Don’t try to be everything—intensive nutritionist, personal trainer, therapist, and prescriber. Stay in your lane (medical management, behavioral support within your expertise) and refer out for specialized nutrition counseling or exercise programming if needed.
Pitfall #2: Underselling Your Value
Some providers race to the bottom on price to compete with $29/month telehealth services. Don’t. You’re not Hims or Ro. You’re a board-certified specialist offering expert, personalized care. Charge accordingly. Patients seeking quality will pay $100-150 for a visit with a psychiatrist who understands their mental health vs. $29 for a nurse who’s seeing 40 patients a day.
Pitfall #3: Poor Patient Selection
Not everyone is a good candidate for GLP-1 therapy, and not every candidate is a good fit for your practice. Screen carefully:
Saying no to poor-fit patients saves you headaches and protects your reputation.
Pitfall #4: Neglecting Follow-Up
Weight loss requires ongoing management. Patients who feel abandoned after the first prescription will either stop treatment (and leave negative reviews) or jump to another provider. Build a solid follow-up system with monthly check-ins at minimum, plus between-visit messaging access.
Pitfall #5: Overpromising Results
Be honest about expected outcomes. Real-world data shows average weight loss of 7-12% after one year, with about half of patients discontinuing within 12 months. Don’t promise ‘guaranteed 50 pounds lost’ or show cherry-picked transformations without context. Set realistic expectations and overdeliver when possible.
Adding weight-loss services to a psychiatric practice isn’t for everyone. Ask yourself:
Do it if:
Don’t do it if:
The Bottom Line
There’s a genuine opportunity here for psychiatric providers willing to invest the time to do it right. The demand is massive and growing. The competition is mostly volume-focused startups—you can win on quality and expertise. And for many of your existing patients, you’d be solving a problem they desperately need help with.
But it requires thoughtfulness. This isn’t about hopping on the GLP-1 gold rush and churning through patients. It’s about integrating metabolic care into a holistic psychiatric practice—treating the whole person, not just prescribing what’s trendy.
If that aligns with your vision for your practice, the path forward is clear:
Get trained: Complete obesity medicine CME, review current GLP-1 guidelines, understand titration protocols and side effect management
Set up operations: Update website, create intake forms specific to weight management, establish medication protocols and pharmacy relationships
Start slow: Begin with existing patients who’d benefit, refine your process
Market strategically: Build content, optimize local SEO, consider platform partnerships to scale patient acquisition efficiently
Deliver exceptional care: Differentiate on expertise and support—be the provider patients wish they’d found first
Scale thoughtfully: As you prove the model works, invest in systems and team to grow sustainably
Done right, weight-loss services can add meaningful revenue, improve patient outcomes, and position you as a forward-thinking provider who treats mental and metabolic health as the connected systems they actually are.
And if the patient acquisition piece feels overwhelming—competing with companies spending millions on marketing—there’s a simpler path: partner with platforms that have already solved that problem and just want great clinicians to see the patients.
Can psychiatrists legally prescribe GLP-1 medications for weight loss?
Yes, absolutely. Psychiatrists are fully licensed physicians who can prescribe any FDA-approved medication within their scope of competence. GLP-1 medications like semaglutide (Wegovy) and tirzepatide (Zepbound) are FDA-approved for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related comorbidities. As long as you’re familiar with the medications, prescribing guidelines, and management protocols—which can be learned through CME courses—you can prescribe them. Many psychiatrists already do, particularly for patients with antipsychotic-induced weight gain.
What about PMHNPs—can they prescribe these medications independently?
It depends on your state. Psychiatric nurse practitioners in full practice authority states (California, New York, Illinois after meeting requirements) can prescribe GLP-1 medications independently once they meet their state’s experience and certification requirements. In restricted practice states (Texas, Pennsylvania, Florida for PMHNPs), you’ll need a collaborative physician agreement. The good news: GLP-1s are not controlled substances, so they don’t carry the
Find the right provider for your needs — select your state to find expert care near you.